Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Remove filter for
Recall class: Type II
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 314 items.
Affected lot(s) may contain the presence of Burkholderia contamination.
RecallHealth product recall | 2023-06-02
Affected lots are incorrectly labelled for use in the subpopulation that is less than 4 years of age.
RecallHealth product recall | 2023-06-01
The dextrose content is out of specification in the affected lot.
RecallHealth product recall | 2023-05-31
Presence of Sorafenib in affected lots.
RecallHealth product recall | 2023-05-31
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-05-30
An impurity is out of specification in the affected lot.
RecallHealth product recall | 2023-05-12
The Anti-Factor Ila potency is out of specification in the affected lot.
RecallHealth product recall | 2023-05-11
Affected lot is missing risk statements on the outer label; Affected lot is labelled with claims that are not compliant with its terms of market authorization; Regulated party does not hold a site licence for sale of the product in Canada.
RecallHealth product recall | 2023-05-05
Product sold without market authorization (DIN) in Canada. Affected lot contains undeclared Dehydrolatanoprost, a prostaglandin analogue. Prostaglandin analogues are listed in the prescription drug list
RecallHealth product recall | 2023-04-27
Unauthorized health products for use in the pediatric subpopulation.
RecallHealth product recall | 2023-04-27
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-04-20
The affected lot may contain contaminants (nylon fibers).
RecallHealth product recall | 2023-04-20
Affected lot may contain over-sized tablets
RecallHealth product recall | 2023-04-20
The affected lot contains an additional excipient (Phosphate Buffer).
RecallHealth product recall | 2023-04-17
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-04-14